GlassScriptPhysician profile
Debra J Werner
NPI 1760577258
$5,996.64
in general payments reported to CMS, 2019-2025
28 companies · $617 in 2025
The $617 reported for 2025 was more than what 79% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $711 · 2021: $1,036 · 2022: $918 · 2023: $729 · 2024: $549 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,761.00 |
| Education | $134.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $1,906.54 | 2019-2025 | Slynd |
| Abbvie INC. | $990.07 | 2019-2023 | Lo Loestrin Fe |
| Evofem Biosciences, INC. | $340.72 | 2020-2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $310.08 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $272.61 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $231.13 | 2024-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $228.09 | 2020-2024 | |
| Lupin INC. | $222.22 | 2019-2020 | |
| Scynexis, INC. | $219.94 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $211.67 | 2022-2025 | |
| Therapeuticsmd, INC. | $147.56 | 2019-2022 | |
| Avion Pharmaceuticals | $135.52 | 2020-2023 | Divigel |
| Myovant Sciences INC. | $104.58 | 2021-2022 | |
| Allergan, INC. | $94.31 | 2019-2020 | |
| Millicent US INC | $91.63 | 2019-2023 | Femring, Intrarosa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $81.36 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $69.14 | 2025 | |
| Coopersurgical, INC. | $59.01 | 2020-2022 | |
| Exact Sciences Corporation | $49.07 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Vertical Pharmaceuticals, LLC | $37.14 | 2019 | |
| Roche Diagnostics Corporation | $37.11 | 2019-2020 | |
| Shield Therapeutics INC | $36.79 | 2025 | |
| Organon LLC | $35.20 | 2022-2024 | Nexplanon |
| Mylan Pharmaceuticals INC. | $19.55 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.45 | 2019 | |
| Duchesnay USA Incorporated | $17.85 | 2019 | |
| Biogen, INC. | $16.89 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Werner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.